533928-74-4 Usage
Description
4-Hydroxy-2,6-bis(1-methylbenzimidazol-2-yl)pyridine is a chemical compound that belongs to the family of benzimidazole derivatives. It features a pyridine backbone with two benzimidazole rings, each adorned with a methyl group. 4-Hydroxy-2,6-bis(1-methylbenzimidazol-2-yl)pyridine is recognized for its potential applications in various fields, including catalysis, coordination chemistry, and the development of metal-organic frameworks. Its capacity to form stable complexes with a range of metal ions, coupled with its potential biological activities such as antimicrobial and antitumor properties, positions it as a valuable asset for both industrial applications and scientific research.
Uses
Used in Coordination Chemistry:
4-Hydroxy-2,6-bis(1-methylbenzimidazol-2-yl)pyridine is used as a ligand for the formation of coordination compounds. Its ability to chelate with metal ions contributes to the stability and properties of the resulting complexes, making it instrumental in the study and application of coordination chemistry.
Used in Catalysis:
In the field of catalysis, 4-Hydroxy-2,6-bis(1-methylbenzimidazol-2-yl)pyridine is employed as a catalyst or a catalyst precursor. Its structural features allow it to facilitate various chemical reactions, enhancing the efficiency and selectivity of the processes.
Used in Metal-Organic Frameworks (MOFs):
4-Hydroxy-2,6-bis(1-methylbenzimidazol-2-yl)pyridine is utilized as a building block in the construction of metal-organic frameworks. These MOFs benefit from the compound's capacity to form stable and porous structures, which are advantageous for applications such as gas storage, separation, and catalysis.
Used in Antimicrobial Applications:
4-Hydroxy-2,6-bis(1-methylbenzimidazol-2-yl)pyridine is studied for its potential as an antimicrobial agent. Its ability to interact with microbial cells and disrupt their functions makes it a candidate for use in combating infections and developing new antimicrobial therapies.
Used in Antitumor Applications:
4-Hydroxy-2,6-bis(1-methylbenzimidazol-2-yl)pyridine is also investigated for its antitumor properties. Its potential to interact with and affect the behavior of tumor cells positions it as a candidate for use in cancer research and the development of novel cancer treatments.
Used in Industrial Applications:
Due to its versatility in forming stable complexes with metal ions, 4-Hydroxy-2,6-bis(1-methylbenzimidazol-2-yl)pyridine is used in various industrial processes where such complexes are required for specific functions, such as in the manufacturing of catalysts or materials with specialized properties.
Check Digit Verification of cas no
The CAS Registry Mumber 533928-74-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,3,3,9,2 and 8 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 533928-74:
(8*5)+(7*3)+(6*3)+(5*9)+(4*2)+(3*8)+(2*7)+(1*4)=174
174 % 10 = 4
So 533928-74-4 is a valid CAS Registry Number.
533928-74-4Relevant articles and documents
Synthesis, crystal structure, electrochemical property, and antioxidant activity of copper(II) complex based on 4-butyloxy-2,6-bis(1-methyl-2-benzimidazolyl)pyridine
Pan, Rong-kai,Li, Guo-bi,Liu, Sheng-gui,Zhou, Xiao-ping,Yang, Gui-zhen
, p. 1189 - 1196 (2016)
Abstract: A new copper(II) complex [Cu(bmbp)Cl2]·DMF, where bmbp is 4-butyloxy-2,6-bis(1-methyl-2-benzimidazolyl)pyridine, was synthesized and characterized by X-ray single-crystal structure analysis. The complex crystallizes in triclinic, space group P-1 with a?=?8.4551(3)??, b?=?12.8262(4)??, c?=?14.7111(5)??, α?=?64.335(3)°, β?=?75.314(3)°, γ?=?86.749(2)°, V?=?1388.42(8)??3, Z?=?2. The Cu(II) ion adopts a distorted trigonal bipyramidal geometry coordinated by three nitrogen atoms of the ligand and two chloride atoms. TG analysis showed that the complex has high thermal stability. Electrochemical measuring exhibited an irreversible one-electron transfer process. DPPH radical scavenging assay showed that the ligand and its Cu(II) complex exhibited much lower antioxidant activity than that of ascorbic acid. Graphical abstract: [Figure not available: see fulltext.]
"Janus-type" ruthenium complex bearing both phosphonic acids and pyrene groups for functionalization of ITO and HOPG surfaces
Yang, Li,Ozawa, Hiroaki,Koumoto, Mayuko,Yoshikawa, Kai,Matsunaga, Mariko,Haga, Masa-Aki
supporting information, p. 160 - 162 (2015/02/19)
A novel Janus-type ruthenium complex bearing both phosphonic acid and pyrene groups was tethered to both ITO and HOPG surfaces in different tethering modes. On the ITO surface, the phosphonic groups were selectively attached to the ITO, resulting in the h
Conjugated polymer with benzimidazolylpyridine ligands in the side chain: Metal ion coordination and coordinative self-assembly into fluorescent ultrathin films
Welterlich, Irina,Tieke, Bernd
scheme or table, p. 4194 - 4203 (2012/05/04)
The synthesis and characteristic properties of a new conjugated copolymer with poly(phenylene-alt-fluorene) main chain and 2,6-bis(1′- methylbenzimidazolyl)pyridine (bip) ligands attached to the main chain via flexible spacer groups are described. The cop
